Study archive · AI simulation with synthetic data · Human validation pending

Initial review — P05

Riley Park, fictional sales operations manager at a hypothetical healthcare-software vendor. This is an AI simulation, not real stakeholder validation. Reviewed R09, then R85, and the supplied schema only; no source links were opened. These judgments precede any follow-up answers.

R09

Next action: The CRM/reporting systems owner should reconcile Neurology taxonomy/mapping, extract filters and feed completeness against the full CRM, document capture time, and return covered records or explicit evidence of zero to Riley. Riley then verifies stages and valid close dates before interpreting exposure or overdue state. Pinned-source calculation checks and account discovery remain necessary before account-level decisions.

Action clear without clarification: Yes. Clarification needed: No. Clarification questions: None. Confidence: High.

Missing evidence includes the full-CRM reconciliation, completeness/mapping/filter evidence, capture timestamp, verified opportunity stages and dates, completed pinned-source validation and account context. These are the substance of the requested investigation, not obstacles to understanding it.

No specific interpretation error is apparent. Neurology coverage is unavailable, so the handoff does not establish zero opportunities, zero ACV or zero overdue exposure. The displayed arithmetic is internally consistent.

Business questions for the next check:

Source/format cues: clearly separated headings and named roles; coordinator/live-app-export wording; browser-usability, local-extract, snapshot-hash and cloud-execution caveats; commit-pinned GitHub links with a Databricks-labelled release path, certification log, receipt and payment-check document. Raw percentages are verbose but rounded in the observation. These cues were noted without inferring study methods.

R85

Next action: The CRM/reporting systems owner should reconcile Cardiology taxonomy/mapping and extract filters against the full CRM, document completeness and capture time, and return covered records or explicit evidence of zero to Riley. Riley verifies stages and close dates before interpreting exposure. Pinned-source calculation checks and account discovery remain necessary before account-level decisions.

Action clear without clarification: Yes. Clarification needed: No. Clarification questions: None. Confidence: High.

Missing evidence includes the full-CRM reconciliation, completeness/mapping/filter evidence, capture timestamp, verified opportunity stages and dates, completed pinned-source validation and account context. These are investigation items already identified by the handoff.

No specific interpretation error is apparent. Cardiology's absence from the supplied extract establishes unavailable coverage, not measured zero. The displayed arithmetic is internally consistent.

Business questions for the next check:

Source/format cues: clearly separated headings and named roles; nine-specialty and 500-row extract descriptions; unknown capture time; commit-pinned GitHub links with a Databricks-labelled release path, certification log and receipt. Raw percentages are verbose but rounded in the observation. These cues were noted without inferring study methods.

Comparison

Both give me an actionable systems/source check with a responsible role and a clear sales-operations follow-up. Neither needs a handoff clarification before work can begin. Both preserve the distinction between unknown coverage and zero, and neither justifies interpreting sales exposure yet. R09 has more operational/provenance caveats and an additional source link; R85 is more compact. The source claims have not been independently verified.